Evidence map›Paper›PMID 40901271›Full record

ArticleJournal of hepatocellular carcinoma2025

Multiparametric MRI-Based Machine Learning Radiomics Prognostic Models for Multifocal Hepatocellular Carcinoma Beyond Milan Criteria: A Retrospective Study.

Xinyue Liang, Fei Wu, Xinde Zheng, Yuyao Xiao, Chun Yang, Mengsu Zeng

Abstract read
In one paragraph

Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinyue Liang *Shanghai Institute of Medical Imaging, Shanghai, People's Republic of China.
Fei Wu *Shanghai Institute of Medical Imaging, Shanghai, People's Republic of China.ORCID 0000-0001-5169-0417
Xinde Zheng *Shanghai Institute of Medical Imaging, Shanghai, People's Republic of China.
Yuyao XiaoShanghai Institute of Medical Imaging, Shanghai, People's Republic of China.
Chun YangShanghai Institute of Medical Imaging, Shanghai, People's Republic of China.
Mengsu ZengShanghai Institute of Medical Imaging, Shanghai, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To develop machine learning radiomics models for preoperative risk stratification of multifocal hepatocellular carcinoma (MHCC) beyond Milan criteria. Methods: Patients with pathologically proven MHCC beyond Milan criteria between January 2015 and January 2019 were retrospectively included. Radiomic features were extracted from tumor, peritumor, and tumor-peritumor regions using multiparametric MRI (mpMRI). An unsupervised spectral clustering algorithm was used to identify radiomics-based patient subtypes. Radiomics risk scores (RRS) for overall survival (OS) and recurrence-free survival (RFS) were generated using supervised extreme gradient boosting (XGBoost)-LASSO Cox proportional hazard regression analysis. The Concordance index (C-Index) was used to evaluate the model performance in the training and validation sets. Results: A total of 156 patients were divided into training (n = 78) and validation (n = 78) groups. Two distinct unsupervised subtypes were identified using spectral clustering, and subtype B was associated with worse OS and poor RFS. Incorporating radiomics predictors into the conventional preoperative clinical-radiological features improved the OS prediction performance (training set: from 0.616 to 0.712; validation set: from 0.522 to 0.710), and RFS prediction (training set: from 0.653 to 0.735; validation set: from 0.574 to 0.698). The combined models showed good predictive performance for 5-year OS (AUC, 0.77) and RFS (AUC, 0.81) in the training set and for 5-year OS (AUC, 0.75) and RFS (AUC, 0.76) in the validation set. Conclusion: Two preoperative models combining mpMRI-based clinico-radiological and radiomics predictors effectively predicted outcomes for patients with MHCC beyond the Milan criteria.

Indexed as

hepatocellular carcinomaMRIradiomicsunsupervised learning

Identifiers

PMID40901271
PMCPMC12401053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.